MedTrace Logo

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

NCT05766891 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2026-03-16

No results posted yet for this study

Summary

To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.

Conditions

Interventions

BEHAVIORAL

Group 2

Participants will receive standard general anesthesia and medications to control your pain after arriving in the operating room

BEHAVIORAL

Group 3

Participants will receive standard general anesthesia and medications during surgery to control your pain.

BEHAVIORAL

Group 1

Participants will receive hypnosedation will be restarted after arriving in the operating room and will continue for the whole time of surgery

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Rising Tide Foundation

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Lorenzo Cohen, MD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-12
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05766891 on ClinicalTrials.gov